Serina Therapeutics (SER) Price to Book (2018 - 2026)

Serina Therapeutics has disclosed Price to Book across 9 years of filings, most recently posting 1.7 for Q2 2026.

• In Q2 2026, Price to Book fell 95.53% year-over-year to 1.7; the TTM figure through Jun 2026 stood at 1.7 (down 95.53% YoY), while the FY2025 annual figure was 555.81, down 865.83% from the prior year.
• Price to Book came in at 1.7 for Q2 2026 at Serina Therapeutics, up from 555.81 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 72.58 in Q4 2024 to a low of 555.81 in Q4 2025.
• Average Price to Book over 5 years is 41.17, with a median of 5.14 recorded in 2024.
• Year-over-year, Price to Book soared 15897.58% in 2024 and slumped 865.83% in 2025.
• Over 5 years, Price to Book stood at 19.8 in 2022, then surged by 97.68% to 0.46 in 2023, then soared by 15897.58% to 72.58 in 2024, then tumbled by 865.83% to 555.81 in 2025, then soared by 100.31% to 1.7 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 1.7 in Q2 2026, 555.81 in Q4 2025, and 32.11 in Q3 2025.